Can you take Ashwagandha (Withania somnifera) and Rhodiola rosea together?

The available evidence is use- and population-specific. Each page documents mechanism, studied or reported dose context, risks, and legal status; the database does not determine whether a combination is appropriate for an individual.

Rankings / Comparisons

Ashwagandha (Withania somnifera) vs Rhodiola rosea

Two adaptogens with overlapping marketing claims and very different evidence bases.

Reviewed by Read Off Label · How we grade

Score comparison

Rhodiola rosea has the higher descriptive composite (B+, 7.1/10) compared with Ashwagandha (Withania somnifera) (B-, 6.3/10). The axes below show whether that difference comes from evidence, reported benefit, safety, or a combination.

Ashwagandha (Withania somnifera)

B- 6.3/10

aka KSM-66, Sensoril

Evidence: Moderate (stress/anxiety; small testosterone effect in men per Lopresti 2019; modest muscle/strength gains) (6/10)
Benefit: Moderate (5/10)
Risk: Low-Med (hepatotoxicity — emerging case reports since 2020; thyroid hormone elevation — caution in hyperthyroidism or on levothyroxine; sedating; theoretical concerns with autoimmune conditions) (7/10 safety)
Legality: OTC
Dose / route context: 300-600 mg/day standardized extract (KSM-66 or Sensoril most studied)
Class: Herbal
Last reviewed: Jun 8, 2026

Read Off Label grades Ashwagandha (Withania somnifera) as B- (6.3/10) based on moderate evidence, moderate benefit magnitude, and a low-med-risk safety profile.

Ashwagandha is widely marketed in Western supplement channels, and multiple clinical trials include Chandrasekhar 2012 and Lopresti 2019 and 2021.

Studied, labeled, or reported-use context: 300-600 mg/day standardized extract (KSM-66 or Sensoril most studied) — OTC; not individualized guidance.

What it is

Ashwagandha is widely marketed in Western supplement channels, and multiple clinical trials include Chandrasekhar 2012 and Lopresti 2019 and 2021. Iceland and Denmark added warnings 2023 after multiple case reports of DILI (drug-induced liver injury). Time separation from thyroid hormone is used because coadministration can affect absorption. Cycling appears in chronic consumer-use protocols but has not been validated in comparative trials. Emerging 2025-2026 case reports describe HPA-axis suppression and withdrawal-type symptoms with chronic use; they are too sparse to establish incidence or whether cycling changes risk. A 2026 meta-analysis (20 RCTs, n=1,249) reported significant cognitive gains - memory SMD 0.52, attention/processing speed SMD 0.29 - plus muscle-strength, testosterone, and body-composition improvements (GRADE-assessed; Front Pharmacol 2026).

Mechanism

Ayurvedic 'Indian ginseng'; withanolides (withaferin A, withanolide D); HPA axis modulation — reduces cortisol response to stress; GABAergic; thyroid-stimulating effects

Full Ashwagandha (Withania somnifera) review →

Rhodiola rosea

B+ 7.1/10

Evidence: Moderate (fatigue, burnout, mild depression, exercise recovery) (6/10)
Benefit: Med (5/10)
Risk: Low (generally well-tolerated) (9/10 safety)
Legality: OTC
Dose / route context: 200-600 mg/day standardized extract (3% rosavin, 1% salidroside)
Class: Herbal
Last reviewed: Aug 13, 2026

Read Off Label grades Rhodiola rosea as B+ (7.1/10) based on moderate evidence, med benefit magnitude, and a low-risk safety profile.

Best-studied adaptogen outside of ashwagandha.

Studied, labeled, or reported-use context: 200-600 mg/day standardized extract (3% rosavin, 1% salidroside) — OTC; not individualized guidance.

What it is

Best-studied adaptogen outside of ashwagandha. Effects generally described as subtle — reduced fatigue and stress tolerance rather than acute stimulation. Most notable in fatigue/burnout states.

Mechanism

Arctic adaptogen; rosavins and salidrosides; modulates HPA axis and monoamine metabolism; reduces cortisol response to stress; mitochondrial support

Full Rhodiola rosea review →

Common questions

How do the evidence profiles of Ashwagandha (Withania somnifera) and Rhodiola rosea compare?: Rhodiola rosea has the higher descriptive composite (B+, 7.1/10) compared with Ashwagandha (Withania somnifera) (B-, 6.3/10). The axes below show whether that difference comes from evidence, reported benefit, safety, or a combination.
What's the difference between Ashwagandha (Withania somnifera) and Rhodiola rosea?: Two adaptogens with overlapping marketing claims and very different evidence bases.
Can you take Ashwagandha (Withania somnifera) and Rhodiola rosea together?: The available evidence is use- and population-specific. Each page documents mechanism, studied or reported dose context, risks, and legal status; the database does not determine whether a combination is appropriate for an individual.

This is an independent synthesis of published research by a non-clinician. The comparison reports composite and axis-level differences without selecting an intervention for the reader. Relevance depends on indication, population, dose, duration, and other context. See the full disclaimer and methodology.